Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers

Author： Dutta S.   Zhang Y.   Selness D.S.   Lee L.L.   Williams L.A.   Sommerville K.W.  

Publisher： Elsevier

ISSN： 0920-1211

Source： Epilepsy Research, Vol.49, Iss.1, 2002-03, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IPX066: a new intermediate- and extended-release carbidopa-levodopa formulation

By Yacoubian Talene A  

Neurodegenerative Disease Management, Vol. 3, Iss. 2, 2013-04 ,pp. : 123-131

Future Medicine

Access to resources Recommend Favorite

A study to evaluate the use of extended release divalproex

By Stone Michael M.   Hirschfeld Robert M.A.  

International Journal of Psychiatry in Clinical Practice, Vol. 8, Iss. 3, 2004-09 ,pp. : 169-171

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Divalproex extended-release versus the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures

By Thibault M.   Blume W.T.   Saint-Hilaire J.-M.   Zakhari R.   Sommerville K.W.  

Epilepsy Research, Vol. 50, Iss. 3, 2002-07 ,pp. : 243-249

Elsevier

Access to resources Recommend Favorite

Carbamazepine Extended-Release Capsules in the Treatment of Bipolar Disorder

By Ginsberg Lawrence  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 1-1

Informa Healthcare

Access to resources Recommend Favorite

Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy

By Doughty J.   Baker G.A.   Jacoby A.   Lavaud V.  

Epilepsy & Behavior, Vol. 4, Iss. 6, 2003-12 ,pp. : 710-716

Elsevier

Access to resources Recommend Favorite